X Gen Pharmaceuticals

X-Gen Pharmaceuticals is a specialty pharmaceutical company that develops, manufactures, and markets generic injectable products for the healthcare industry. The company focuses on niche therapeutic areas including anti-infectives, ophthalmics, and specialty hospital medications. Headquartered in Big Flats, New York, X-Gen maintains a portfolio of essential generic drugs such as vancomycin and clindamycin. In 2019, the company was acquired by Gland Pharma, a global leader in injectable manufacturing, to strengthen its presence in the United States market. X-Gen continues to operate as a key provider of high-quality, cost-effective generic alternatives for clinical settings. The company's business model emphasizes reliability in the supply chain for critical care medications.